News LEO Pharma's Adtralza approved by MHRA, EC for adolescent at... The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have
News Neumora laid low by depression trial failure The first of three phase 3 trials of Neumora's novel antidepressant navacaprant has ended in failure, wreaking havoc with its share price.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
